15.06.2010 • NewsDSMLawsuitKautschuk

DSM Announces Settlement Of Federal Class Antitrust Litigation

A class of businesses that purchased ethylene proplylene diene monomer (EPDM) between 1997 and 2001 has reached agreement with two subsidiaries of Royal DSM to settle a long-running antitrust dispute before trial in return for a payment of $25 million.

The EPDM class action, pending in the U.S. District Court for the District of Connecticut, was vigorously litigated by both sides; the DSM defendants consistently denied any wrongdoing in connection with the allegations. In 2006, competition enforcement authorities in the EU, U.S. and Canada concluded their EPDM investigations without bringing any charges against DSM or any of its employees. The DSM defendants have now entered into the settlement to eliminate the burden, expense and risk of further litigation. The proposed class action settlement is subject to Court approval.

If approved, and following due notice to the class members, the class action will be dismissed with prejudice and all claims asserted in the class action against the DSM defendants will be released.

 

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.